Taichung, Taiwan

Jiin-Tarng Wang

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Fbd Biologics Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiin-Tarng Wang. Retrieved from https://idiyas.com/inventor/jiin-tarng-wang-udgul1fq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiin-Tarng Wang: Innovator in Engineered SIRPα Variants

Introduction

Jiin-Tarng Wang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of engineered SIRPα variants. His work has implications for various medical applications, showcasing his innovative approach to solving complex biological challenges.

Latest Patents

Jiin-Tarng Wang holds a patent for "Engineered SIRPα variants and methods of use thereof." This patent relates to engineered SIRPα variants and outlines methods for their use, highlighting his expertise in the field.

Career Highlights

Wang is currently associated with FBD Biologics Limited, where he continues to advance his research and development efforts. His work at the company reflects his commitment to innovation in biotechnology.

Collaborations

Throughout his career, Jiin-Tarng Wang has collaborated with talented individuals such as Han-Fang Teng and Pan-Hsien Kuo. These collaborations have enriched his research and contributed to the advancement of their shared goals in the field.

Conclusion

Jiin-Tarng Wang's contributions to the development of engineered SIRPα variants exemplify his innovative spirit and dedication to biotechnology. His work continues to influence the field and inspire future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…